Home Tags Posts tagged with "serum institute of india"

serum institute of india

Ghana has become the first country to receive Covid-19 vaccines through the Covax vaccine-sharing initiative.

A delivery of 600,000 doses of the AstraZeneca vaccine arrived in Accra on February 24. The first recipients are due to be healthcare workers.

The Covax scheme aims to reduce the divide between rich countries and poorer nations unable to buy doses.

The program is planning to deliver about two billion vaccine doses globally by the end of the year.

Ghana, which has a population of over 30 million, was chosen as the first recipient of the free vaccines after promising quick distribution and meeting the criteria set by Covax.

Further deliveries are expected to neighboring Ivory Coast later this week, the Covax alliance says.

Vaccinations are expected to start in Ghana next week, and, as well as health workers, those over 60, people with underlying health conditions, and senior officials are due to be prioritized.

The vaccines delivered to Accra were produced by the Serum Institute of India and developed by AstraZeneca and Oxford University. The vaccine has been approved by the WHO and its roll-out in Ghana is not part of a trial.

Covid-19 Vaccine: Israel Leads the World in Vaccination Rate

The doses being sent to lower-income countries such as Ghana are funded by donations. As well as procuring and delivering the vaccines, Covax partners are supporting local authorities in areas such as training people to administer the vaccine and helping provide an adequate cold-chain storage and delivery system.

Many nations in the developed world, which began their own vaccinations months ago, have faced criticism for buying or ordering more vaccines than they need.

However, many of those countries placed orders for doses with pharmaceutical companies before knowing whether the vaccine in development would be effective. They were hedging their bets – placing multiple orders in the hope that at least some of them would work out.

The Covax scheme is led by the WHO and also involves the Global Vaccine Alliance (GAVI) and the Coalition for Epidemic Preparedness Innovations (CEPI).

In a joint statement, the WHO and the United Nations children’s fund (UNICEF) said it was a momentous occasion and “critical in bringing the pandemic to an end”.

Image source: AP

Five people have died in a fire at Serum Institute of India, the world’s largest vaccine manufacturer.

The fire started at a building which was still under construction at the Serum Institute facilities in Pune on January 21.

Footage showed thick plumes of smoke billowing from a building on the company’s sprawling site.

However, the company said vaccine production would not be affected. The cause of the fire has not been identified.

The blaze was later brought under control, but the city’s mayor confirmed that five people had died.

Serum Institute’s CEO Adar Poonawalla tweeted: “We have just received some distressing updates; upon further investigation we have learnt that there has unfortunately been some loss of life at the incident.

“We are deeply saddened and offer our deepest condolences to the family members of the departed.”

Adar Poonawalla said there would be no impact on the production of the Oxford-AstraZeneca vaccine, known locally as Covishield, “due to multiple production buildings that I had kept in reserve to deal with such contingencies”.

Coronavirus: India in Total Lockdown for 21 Days

Coronavirus: India Observes 14-Hour Janata Curfew to Combat Pandemic

Covishield is one of two vaccines approved by the Indian government for use in its inoculation program, which began last week and is the largest in the world.

India aims to vaccinate 300 million people by early August.

Many other low and middle-income countries are also depending on the Serum Institute for production of the Oxford-AstraZeneca vaccine.

India has recorded the second-highest number of Covid-19 infections in the world after the United States. Since the pandemic began India has confirmed more than 10.6 million cases and almost 153,000 deaths, according to figures from Johns Hopkins University.